School of Medicine
Showing 31-40 of 616 Results
-
Harmeet Bedi
Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Harmeet Bedi is the Director of Interventional Pulmonology & Bronchoscopy at Stanford University. His expertise is in minimally invasive techniques used in the diagnosis and treatment of various airway and lung diseases such as lung cancer, benign & malignant airway obstruction, and pleural diseases. He specializes in rigid & flexible bronchoscopy, robotic bronchoscopy, airway stent placement, balloon bronchoplasty, endobronchial ultrasound (EBUS), and various pleural procedures. He also specializes in a variety of tumor ablative therapies including laser therapy, electrocautery, argon plasma coagulation (APC), brachytherapy, and cryotherapy.
He founded the cone-beam computed tomography (CBCT) - guided bronchoscopy program at Stanford in 2019. CBCT-guided bronchoscopy is a novel and cutting-edge technique which combines bronchoscopy with CT imaging, allowing for improved localization and diagnosis of peripheral lung nodules. Additionally, CBCT-guided bronchoscopy will allow for numerous potential cancer therapies that are currently under development.
Dr. Bedi is a principal investigator and co-investigator on multiple clinical trials related to bronchoscopy, thoracic imaging, pulmonary nodules, and lung cancer. Specifically, he has multiple research interests within the realm of bronchoscopic device innovation and CBCT-guided bronchoscopy. -
Corinne Beinat
Assistant Professor of Radiology (Molecular Imaging Program at Stanford)
Current Research and Scholarly InterestsThe focus of my research is to develop novel imaging and treatment strategies to detect and better manage cancer. This approach relies first on the identification and validation of molecular targets and biomarkers that are linked with underlying the underlying biology driving the initiation and progression of cancers. We then develop novel small molecule based radiotracers to monitor fundamental molecular and cellular processes occurring in living subjects using positron emission tomography (PET) with the goal of improving cancer diagnosis and management. We additionally develop novel peptide based theragnostic agents for stratification of patients with high receptor expression, treatment with targeted radionuclide therapy, and subsequent monitoring of treatment response. Our overall goal is to develop multiple clinically translatable strategies to improve cancer diagnosis, management, and outcomes.
-
Gill Bejerano
Professor of Developmental Biology, of Computer Science, of Pediatrics (Genetics) and of Biomedical Data Science
Current Research and Scholarly Interests1. Automating monogenic patient diagnosis.
2. The genomic signatures of independent divergent and convergent trait evolution in mammals.
3. The logic of human gene regulation.
4. The reasons for sequence ultraconservation.
5. Cryptogenomics to bridge medical silos.
6. Cryptogenetics to debate social injustice.
7. Managing patient risk using machine learning.
8. Understanding the flow of money in the US healthcare system. -
Sean Bendall
Associate Professor of Pathology
Current Research and Scholarly InterestsOur goal is to understand the mechanisms regulating the development of human systems. Drawing on both pluripotent stem cell biology, hematopoiesis, and immunology, combined with novel high-content single-cell analysis (CyTOF – Mass Cytometry) and imagining (MIBI-Multiplexed Ion Beam Imaging) we are creating templates of ‘normal’ human cellular behavior to both discover novel regulatory events and cell populations as well as understand dysfunctional processes such as cancer.
-
Catherine Benedict, PhD
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Current Research and Scholarly InterestsMy research focuses on improving cancer survivorship through better understanding of long-term health outcomes and through the development of theoretically driven, evidence-based behavioral interventions to improve adjustment, risk management, and quality of life. To this end, I lead studies aimed to guide and support patient decision-making and self-management after cancer. Much of my work focuses on the experiences of young adults affected by cancer.
-
Jonathan S. Berek, MD, MMSc
Laurie Kraus Lacob Professor
BioLaurie Kraus Lacob Professor
Stanford University School of Medicine
Founding Director, Stanford Women’s Cancer Center
Senior Advisor, Stanford Cancer Institute
Co-Chair, Senior Academy at Stanford Medicine
President, Stanford University Phi Beta Kappa
Director, MedArts Films
Faculty Director, Health Communication
Stanford Center for Health Education
A Stanford faculty member since 2005, Professor Berek is renowned for his many contributions to and expertise in gynecologic oncology, especially surgical innovation and techniques, and his research in immunology and immunotherapy. Through many laboratory and clinical investigations, he pioneered the use of regionally-administered immunotherapy in ovarian cancer patients. His early laboratory research focused on fundamental mechanisms of cancer immunology, elucidating growth regulatory pathways for cytokines and their receptors. His current research focuses on clinical trials of novel therapies and immunotherapies for ovarian cancer and collaborations on new diagnostics, screening techniques, and genetics.
An author and editor, Professor Berek has published more than 360 peer-reviewed manuscripts in the scientific literature, and numerous book chapters and monographs. His books, Berek & Hacker’s Gynecologic Oncology, now in its 7th edition, and Berek & Novak’s Gynecology, in its 17th edition, are leading texts in the field. He is the Series Editor for Operative Techniques in Gynecologic Surgery, for which five textbooks on various subspecialty topics in Obstetrics and Gynecology have been published. He serves as the Editor-in-Chief for Current Opinion in Obstetrics & Gynecology, and he is a former Editor-in-Chief of ASCO Connection, published by the American Society of Clinical Oncology.
Professor Berek received his Bachelor of Arts degree in English Literature and Theatre Arts, and a Master of Medical Sciences degree in biomedical sciences from Brown University. After earning his Doctor of Medicine from Johns Hopkins University School of Medicine, he completed an internship and residency at Harvard Medical School, Brigham & Women’s Hospital. Before moving to Stanford, he was on the faculty at the UCLA School of Medicine for more than two decades.
Professor Berek has received many honors and accolades. Dr. Berek is the 2019 Lifetime Achievement Honoree of the American Cancer Society for his many accomplishments in women’s cancer treatment and research. In 2022, he received a Lifetime Achievement Award from the International Society of Gynecologic Cancer for his contributions to the field of gynecologic oncology.
In addition to his medical career, Professor Berek is an active documentary filmmaker—creating and directing films on a variety of medical topics that are highlighted by patient stories. He is the Director and Producer of MedArts Films https://vimeo.com/medarts/videos. He directed a series of films for the Stanford Office of Medical Development, and many short films for the Stanford Center for Health Education that are found on YouTube at the Stanford Medicine Health Shelf. https://www.youtube.com/@Stanford_CHE/playlists
In collaboration with the Under One Umbrella Committee and Stanford Medical Center Development, Professor Berek has led a highly successful fundraising program for the Stanford Women’s Cancer Center. Since 2009, these Under One Umbrella philanthropy efforts have generated substantial support for innovative research programs in women’s cancer via concerts headlined by celebrities, including Nicole Kidman, Keith Urban, Trisha Yearwood, Garth Brooks, Tom Hanks, Rita Wilson, Carrie Underwood, Sheryl Crow, Vince Gill, Amy Grant, Darlene Love, and Harry Connick Jr.
https://www.facebook.com/StanfordWomensCancerCenter/ -
Dominique Bergmann
Shirley R. and Leonard W. Ely, Jr. Professor of the School of Humanities and Sciences
Current Research and Scholarly InterestsWe use genetic, genomic and cell biological approaches to study cell fate acquisition, focusing on cases where cell fate is correlated with asymmetric cell division.
-
Daniel Bernstein
Alfred Woodley Salter and Mabel G. Salter Endowed Professor of Pediatrics
Current Research and Scholarly Interests1. Using iPSC-derived cardiomyocytes to understand hypertrophic cardiomyopathy and heart failure associated with congenital heart disease.
2. Role of alterations in mitochondrial dycamics and function in normal physiology and disease.
3. Differences between R and L ventricular responses to stress,
4. Immune biomarkers of risk after pediatric VAD implantation.
5. Biomarkers for post-transplant lymphoproliferative disorder. -
Alice Bertaina MD, PhD
Lorry I. Lokey Professor
Current Research and Scholarly InterestsDr. Bertaina is a highly experienced clinician and will play a key role in supporting Section Chief Dr. Rajni Agarwal and Clinical Staff in the Stem Cell Transplant Unit at Lucile Packard Children’s Hospital. She will also continue her research on immune recovery and miRNA, understanding the mechanisms underlying immune reconstitution, Graft-versus-Host Disease (GvHD), and leukemia relapse after allogeneic HSCT in pediatric patients affected by hematological malignant and non-malignant disorders.
